Industry Insights

31. What's Ahead For Medical Device Manufacturers 2/24/2026

    Medical device manufacturers face growing complexity in 2026, needing stronger partnerships, advanced biomaterials, and resilient supply strategies to meet shifting patient, regulatory, and global market demands.

32. The Strategic Power Of Medical Device Coatings 2/24/2026

    Medical device coatings are shifting from basic finishes to strategic tools that boost performance, safety, sustainability, and innovation through stronger partnerships, smarter materials, and collaborative development.

33. Robotics And AI In Pharma: Driving The Next Wave Of Innovation 2/23/2026

    Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.

34. Capillary Tubing Connectors Using Tubing Sleeves Instruction Guide 2/22/2026

    IDEX Health & Science provides clear, low–dead-volume guidance for sleeved capillary tubing, ensuring proper fit, flush alignment, and secure, leak-free connections for single or multi-lumen assemblies.

35. Achieve Leak Free And Safe Connections With Tubing Sleeves 2/22/2026

    Tubing sleeves simplify capillary connections, reducing leaks, dead volume, and complexity while providing reliable, high-pressure, and temperature-resistant solutions for life science and medical applications.

36. Managing Risk In The Most Complex Combination Device Format 2/18/2026

    Autoinjectors add mechanical forces and interactions that change how container closure integrity must be evaluated. Learn why device complexity creates new risks and how testing strategies must adapt.

37. EO Sterilization In Transition: Regulatory Shifts And Industry Impact 2/17/2026

    Ethylene oxide sterilization is transforming. Manufacturers must adopt risk-based approaches and optimized cycles to meet rigorous emission controls and patient safety limits for sensitive populations.

38. Cybersecurity And Medical Devices: Understanding Classes And Risk 2/17/2026

    A device's FDA class fails to account for modern cyber exposure. Learn why software architecture and connectivity require independent security assessments to protect patient data and ensure compliance.

39. Part II: Defining The Dye Ingress Operating Window 2/12/2026

    Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

40. Extractables And Leachables: A Critical Part Of CCS Under EU GMP Annex 1 2/4/2026

    Managing chemical migration from packaging and process equipment is essential to protect patient safety, maintain drug stability, and ensure regulatory compliance.